Stephanie Brady Witte

Stephanie Brady Witte possesses extensive experience in oncology commercialization and forecasting, currently serving as Director of US Oncology Commercialization Analytics and Director of US Oncology Forecasting at Bristol Myers Squibb since July 2020. Prior to this role, Stephanie contributed to Teva Pharmaceuticals from May 2011 to July 2020, advancing through various positions including Associate Director of New Product Execution & Forecasting and Sr. Manager of New Product Execution & Forecasting. Stephanie's career began at Starbucks (Aramark) as a Student Manager from February 2007 to May 2011. Educational qualifications include a Master of Science in Forensic Science and Law and a Bachelor of Arts in Biochemistry from Duquesne University.